0001193125-25-129488 Sample Contracts
TEVA PHARMACEUTICAL FINANCE NETHERLANDS IV B.V., as Issuer TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee SENIOR INDENTURE Dated as of May 28, 2025Senior Indenture • May 28th, 2025 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations
THIS INDENTURE, dated as of May 28, 2025, by and among Teva Pharmaceutical Finance Netherlands IV B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation (the “Trustee”),
TEVA PHARMACEUTICAL FINANCE NETHERLANDS IV B.V., as Issuer, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL SENIOR INDENTURE Dated as of May 28, 2025 to the Senior Indenture dated as...First Supplemental Senior Indenture • May 28th, 2025 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL SENIOR INDENTURE, dated as of May 28, 2025, by and among Teva Pharmaceutical Finance Netherlands IV B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”) and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”).
TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V., as Issuer, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, THE BANK OF NEW YORK MELLON, as Trustee and THE BANK OF NEW YORK MELLON, LONDON BRANCH, as Paying Agent FIFTH SUPPLEMENTAL SENIOR...Fifth Supplemental Senior Indenture • May 28th, 2025 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
FIFTH SUPPLEMENTAL SENIOR INDENTURE, dated as of May 28, 2025, by and among Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”) and The Bank of New York Mellon, London Branch, as paying agent (the “Paying Agent”).